Preliminary investigation of intraperitoneal raltitrexed in patients with gastric cancer

BACKGROUND: Peritoneal implantation metastasis of gastric cancer is the major reason for cancer recurrence after radical operations. As a new chemotherapeutic agent, raltitrexed has been widely used in intravenous chemotherapy for many kinds of cancers. However, no study has reported the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ping, Ding, Zhi, Tang, Lingchao, Zhou, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396911/
https://www.ncbi.nlm.nih.gov/pubmed/25547003
http://dx.doi.org/10.1186/1477-7819-12-403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396911/
https://www.ncbi.nlm.nih.gov/pubmed/25547003
http://dx.doi.org/10.1186/1477-7819-12-403

Ejemplares similares